DICERNA

Serial Number 88694422
Registration 7115639
700

Registration Progress

Application Filed
Nov 15, 2019
Under Examination
May 26, 2020
Approved for Publication
Mar 31, 2020
Published for Opposition
Mar 31, 2020
Registered
Jul 18, 2023

Trademark Image

DICERNA

Basic Information

Serial Number
88694422
Registration Number
7115639
Filing Date
November 15, 2019
Registration Date
July 18, 2023
Published for Opposition
March 31, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 18, 2023
Registration
Registered
Classes
042

Rights Holder

Dicerna Pharmaceuticals, Inc.

03
Address
75 Hayden Avenue
Lexington, MA 02421

Ownership History

Dicerna Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Dicerna Pharmaceuticals, Inc.

Owner at Publication
03
Lexington, MA

Dicerna Pharmaceuticals, Inc.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Bridget H. Labutta

USPTO Deadlines

Next Deadline
1348 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-07-18)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jul 18, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 18, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 15, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 14, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 31, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 26, 2023 IUAF S USE AMENDMENT FILED Loading...
May 26, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 7, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 7, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 7, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 3, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 2, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 22, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Nov 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 25, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 25, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 25, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 25, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 25, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
May 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 2, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 2, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 2, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 13, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 13, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 13, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 5, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 5, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 5, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 5, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 5, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 17, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 25, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 25, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
May 25, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 25, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 25, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 25, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 1, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 27, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 27, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 27, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 26, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 31, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...

Detailed Classifications

Class 042
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
First Use Anywhere: May 26, 2023
First Use in Commerce: May 26, 2023

Additional Information

Design Mark
The mark consists of "DICERNA" in stylized white letters on a blue background.
Color Claim
The color(s) white and blue is/are claimed as a feature of the mark.

Classification

International Classes
042